Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma
出版年份 2019 全文链接
标题
Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma
作者
关键词
Medulloblastoma, Subgroup, Prognosis, Signaling pathway, Metabolic pathway, Targeted therapy
出版物
BMC CANCER
Volume 19, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-06-11
DOI
10.1186/s12885-019-5742-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer
- (2018) Nicholas S. Akins et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Signaling Pathways Regulating Redox Balance in Cancer Metabolism
- (2018) Maria Chiara De Santis et al. Frontiers in Oncology
- Notch Signaling in the Tumor Microenvironment
- (2018) Olivier Meurette et al. CANCER CELL
- Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma
- (2018) Ae Kyung Park et al. NEURO-ONCOLOGY
- Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study
- (2017) Edward C Schwalbe et al. LANCET ONCOLOGY
- The whole-genome landscape of medulloblastoma subtypes
- (2017) Paul A. Northcott et al. NATURE
- Notch Shapes the Innate Immunophenotype in Breast Cancer
- (2017) Qiang Shen et al. Cancer Discovery
- Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
- (2016) Vijay Ramaswamy et al. ACTA NEUROPATHOLOGICA
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival
- (2016) Daibiao Xiao et al. MOLECULAR CELL
- Treating cancer with selective CDK4/6 inhibitors
- (2016) Ben O'Leary et al. Nature Reviews Clinical Oncology
- FOXM1 participates in PLK1-regulated cell cycle progression in renal cell cancer cells
- (2016) ZHE ZHANG et al. Oncology Letters
- Lipid metabolic reprogramming in cancer cells
- (2016) S Beloribi-Djefaflia et al. Oncogenesis
- Fundamentals of cancer metabolism
- (2016) R. J. DeBerardinis et al. Science Advances
- Novel Therapeutic Targets of Tumor Metabolism
- (2015) Rigel J. Kishton et al. CANCER JOURNAL
- Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study
- (2015) Lindsey M. Hoffman et al. CHILDS NERVOUS SYSTEM
- Over-expression of FoxM1 is associated with adverse prognosis and FLT3-ITD in acute myeloid leukemia
- (2014) Long-long Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors
- (2014) Jordi Rodon et al. INVESTIGATIONAL NEW DRUGS
- Cytogenetic Prognostication Within Medulloblastoma Subgroups
- (2014) David J.H. Shih et al. JOURNAL OF CLINICAL ONCOLOGY
- Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy
- (2014) B T Gjertsen et al. LEUKEMIA
- Characterization of the Novel and Specific PI3K Inhibitor NVP-BYL719 and Development of the Patient Stratification Strategy for Clinical Trials
- (2014) C. Fritsch et al. MOLECULAR CANCER THERAPEUTICS
- Targeting forkhead box transcription factors FOXM1 and FOXO in leukemia (Review)
- (2014) HONG ZHU ONCOLOGY REPORTS
- Mitochondrial One-Carbon Metabolism Maintains Redox Balance during Hypoxia
- (2014) I. Martinez-Reyes et al. Cancer Discovery
- Medulloblastoma molecular dissection
- (2013) Marc Remke et al. CURRENT OPINION IN ONCOLOGY
- Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas
- (2013) Jonathan W. Friedberg et al. JOURNAL OF CLINICAL ONCOLOGY
- The roles of FOXM1 in pancreatic stem cells and carcinogenesis
- (2013) Ming Quan et al. Molecular Cancer
- The rationale for targeted therapies in medulloblastoma
- (2013) Tobey J. MacDonald et al. NEURO-ONCOLOGY
- Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
- (2012) Marcel Kool et al. ACTA NEUROPATHOLOGICA
- The FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma
- (2012) M Dibb et al. BRITISH JOURNAL OF CANCER
- Regorafenib for cancer
- (2012) Dirk Strumberg et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Molecular subgroups of medulloblastoma
- (2012) Paul A Northcott et al. Expert Review of Neurotherapeutics
- Medulloblastoma stem cells: where development and cancer cross pathways
- (2012) Branavan Manoranjan et al. PEDIATRIC RESEARCH
- Molecular subgroups of medulloblastoma: the current consensus
- (2011) Michael D. Taylor et al. ACTA NEUROPATHOLOGICA
- FOXM1: From cancer initiation to progression and treatment
- (2011) Chuay-Yeng Koo et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Initial testing (stage 1) by the pediatric preclinical testing program of RO4929097, a γ-secretase inhibitor targeting notch signaling
- (2011) E. Anders Kolb et al. PEDIATRIC BLOOD & CANCER
- Targeting Polo-like Kinase in Cancer Therapy
- (2010) Y. Degenhardt et al. CLINICAL CANCER RESEARCH
- Medulloblastoma Comprises Four Distinct Molecular Variants
- (2010) Paul A. Northcott et al. JOURNAL OF CLINICAL ONCOLOGY
- Milatuzumab – a promising new immunotherapeutic agent
- (2009) Zuzana Berkova et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- FoxM1 Is a General Target for Proteasome Inhibitors
- (2009) Uppoor G. Bhat et al. PLoS One
- A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer
- (2008) E. R. Brown et al. ANNALS OF ONCOLOGY
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression
- (2008) Zheng Fu et al. NATURE CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started